T. Schulz-utermoehl

发表

Differential Effect of Troglitazone on the Human Bile Acid Transporters, MRP2 and BSEP, in the PXB Hepatic Chimeric Mouse

I. Wilson, Y. Morikawa, J. Foster, 2012, Toxicologic pathology.

In vitro models of xenobiotic metabolism in trout for use in environmental bioaccumulation studies

K. Chipman, S. Owen, S. Sarda, 2013, Xenobiotica; the fate of foreign compounds in biological systems.

In Vitro Hepatic Metabolism of Cediranib, a Potent Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor: Interspecies Comparison and Human Enzymology

S. Sarda, T. Schulz-utermoehl, N. Bushby, 2010, Drug Metabolism and Disposition.

Expression and localisation of CYP2D enzymes in rat basal ganglia

C. Marsden, R. Edwards, A. Boobis, 1999, Brain Research.

In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acid

I. Wilson, J. G. Kenna, S. Stahl, 2013, Archives of Toxicology.

Structure-function analysis of human CYP3A4 using a specific proinhibitory antipeptide antibody.

R. Bywater, K. Madsen, T. Schulz-utermoehl, 2000, Drug metabolism and disposition: the biological fate of chemicals.

OF HUMAN CYP 3 A 4 USING A SPECIFIC PROINHIBITORY ANTIPEPTIDE ANTIBODY

R. Bywater, K. Madsen, T. Schulz-utermoehl, 2000 .

Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression.

G. Tucker, R. Edwards, A. Boobis, 1999, Pharmacogenetics.

A semi-automated method for measuring the potential for protein covalent binding in drug discovery.

M. Beconi, R. White, T. Schulz-utermoehl, 2005, Journal of pharmacological and toxicological methods.

Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies.

R. Edwards, A. Boobis, T. Schulz, 2001, Biochimica et biophysica acta.

Pharmacokinetics and metabolism of midazolam in chimeric mice with humanised livers

I. Wilson, M. Hutchison, J. Swales, 2012, Xenobiotica; the fate of foreign compounds in biological systems.

Diclofenac metabolism in the mouse: Novel in vivo metabolites identified by high performance liquid chromatography coupled to linear ion trap mass spectrometry

I. Wilson, S. Sarda, T. Schulz-utermoehl, 2012, Xenobiotica; the fate of foreign compounds in biological systems.

Characterisation and identification of the human N+-glucuronide metabolite of cediranib.

E. Lenz, T. Schulz-utermoehl, M. Harrison, 2010, Journal of pharmaceutical and biomedical analysis.